4-9782151-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000798.5(DRD5):āc.122T>Cā(p.Val41Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,576,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000798.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DRD5 | NM_000798.5 | c.122T>C | p.Val41Ala | missense_variant | 1/1 | ENST00000304374.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DRD5 | ENST00000304374.4 | c.122T>C | p.Val41Ala | missense_variant | 1/1 | NM_000798.5 | P1 | ||
SLC2A9 | ENST00000503803.5 | n.386-2086A>G | intron_variant, non_coding_transcript_variant | 3 | |||||
SLC2A9 | ENST00000508585.5 | n.182-10782A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152226Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000125 AC: 26AN: 207622Hom.: 0 AF XY: 0.000134 AC XY: 15AN XY: 111704
GnomAD4 exome AF: 0.000150 AC: 214AN: 1424252Hom.: 0 Cov.: 30 AF XY: 0.000149 AC XY: 105AN XY: 704238
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152226Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.122T>C (p.V41A) alteration is located in exon 1 (coding exon 1) of the DRD5 gene. This alteration results from a T to C substitution at nucleotide position 122, causing the valine (V) at amino acid position 41 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at